Maternal Periodontal Status and Cytokines in Preeclampsia
Launched by HACER SAHIN AYDINYURT · Mar 22, 2017
Trial Information
Current as of July 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Aged between 18 and 45 years
- • 25 and 40 weeks of gestation.
- • Healthy pregnants, mild and severe preeclampsia
- Exclusion Criteria:
- • Patients with accompanying diseases
- • multiple gestations
- • congenital abnormalities were excluded from the study.
About Hacer Sahin Aydinyurt
Hacer Sahin Aydinyurt is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and innovation. With a focus on fostering collaborations between researchers and healthcare professionals, the organization aims to facilitate the development of new therapies and treatments across various disease areas. By prioritizing ethical standards and regulatory compliance, Hacer Sahin Aydinyurt strives to enhance patient outcomes and contribute to the scientific community through rigorous clinical trials and comprehensive data analysis. Their expertise in managing complex studies ensures the efficient progression of research initiatives while maintaining a patient-centered approach.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials